American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$310M |
| 2 |
AbbVie
ABBV
|
+$279M |
| 3 |
L3Harris
LHX
|
+$251M |
| 4 |
VeriSign
VRSN
|
+$238M |
| 5 |
Jacobs Solutions
J
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$510M |
| 2 |
Texas Instruments
TXN
|
+$504M |
| 3 |
Adobe
ADBE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$378M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Intel
INTC
$509B
| $123M | 0.1% |
3,284,146
+778,603
| +31% | +$33.7M |
|
227
TransDigm Group
TDG
$68.3B
| $123M | 0.1% |
228,353
+220,632
| +2,858% | +$130M |
|
228
Korn Ferry
KFY
$4.28B
| $122M | 0.1% |
2,110,254
+234,287
| +12% | +$14.2M |
|
229
J.M. Smucker
SJM
$12.7B
| $122M | 0.1% |
952,765
+230,721
| +32% | +$30.8M |
|
230
Yeti Holdings
YETI
$3.85B
| $121M | 0.1% |
2,807,551
+14,145
| +0.5% | +$687K |
|
231
Abbott
ABT
$192B
| $121M | 0.1% |
1,113,654
-261,031
| -19% | -$29.6M |
|
232
Compass Diversified
CODI
$908M
| $120M | 0.1% |
5,609,213
-316,070
| -5% | -$7.19M |
|
233
Gilead Sciences
GILD
$168B
| $119M | 0.1% |
1,928,878
+1,301,884
| +208% | +$80.6M |
|
234
Atlassian
TEAM
$39.4B
| $119M | 0.1% |
636,032
-191,277
| -23% | -$40.8M |
|
235
Steris
STE
$23.1B
| $119M | 0.1% |
577,980
-575,611
| -50% | -$130M |
|
236
Clarivate
CLVT
$1.19B
| $117M | 0.1% |
8,429,754
-18,527
| -0.2% | -$277K |
|
237
GFL Environmental
GFL
$14.7B
| $116M | 0.1% |
4,512,451
+968,871
| +27% | +$28.7M |
|
238
TJX Companies
TJX
$169B
| $116M | 0.09% |
2,074,470
+1,421,540
| +218% | +$86M |
|
239
Old National Bancorp
ONB
$10.4B
| $115M | 0.09% |
7,784,750
+306,144
| +4% | +$4.72M |
|
240
Heartland Express
HTLD
$950M
| $115M | 0.09% |
8,259,868
+132,152
| +2% | +$1.83M |
|
241
Bio-Techne
TECH
$11.3B
| $113M | 0.09% |
1,306,636
-43,588
| -3% | -$4.08M |
|
|
CHX
242
DELISTED
ChampionX
CHX
| $113M | 0.09% |
5,703,666
-23,154
| -0.4% | -$523K |
|
243
Hanover Insurance
THG
$7.74B
| $113M | 0.09% |
773,611
+689,849
| +824% | +$101M |
|
244
Avnet
AVT
$7.98B
| $112M | 0.09% |
2,622,521
-579,566
| -18% | -$25.3M |
|
245
VICI Properties
VICI
$28.7B
| $112M | 0.09% |
3,767,234
+2,401,411
| +176% | +$70.8M |
|
246
Edgewell Personal Care
EPC
$1.32B
| $110M | 0.09% |
3,193,535
+64,976
| +2% | +$2.34M |
|
247
Essex Property Trust
ESS
$18.1B
| $110M | 0.09% |
419,409
-71,694
| -15% | -$21.7M |
|
248
Rockwell Automation
ROK
$50.1B
| $109M | 0.09% |
547,679
-579,626
| -51% | -$131M |
|
249
Neurocrine Biosciences
NBIX
$15.9B
| $108M | 0.09% |
1,112,832
+316,984
| +40% | +$29.3M |
|
250
Verisk Analytics
VRSK
$23.5B
| $106M | 0.09% |
615,006
+20,802
| +4% | +$3.88M |
|
Similar funds
American Century Companies's Q2 2022 Portfolio in Review
As of Q2 2022, American Century Companies held 2,437 positions worth $122B, down 16% from $146B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q2 2022 filing shows 146 new, 1,442 increased, 596 reduced and 133 closed positions. Its largest new stake was Maravai LifeSciences: 2,396,740 shares worth $68.1M. The largest sale was Meta Platforms (Facebook), an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2022 buy was Maravai LifeSciences: 2,396,740 shares worth $68.1M.
- American Century Companies added most to NVIDIA in Q2 2022, an estimated $310M increase.
- American Century Companies's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $510M.
- American Century Companies fully exited iShares Russell Mid-Cap Value ETF in Q2 2022, selling an estimated $278M.
- American Century Companies's ten largest holdings make up 21% of its $122B portfolio in Q2 2022.
- American Century Companies opened 146 new positions and closed 133 in Q2 2022.
- American Century Companies's portfolio value fell 16% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.